Compare ODC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODC | AORT |
|---|---|---|
| Founded | 1941 | 1984 |
| Country | United States | United States |
| Employees | N/A | 1800 |
| Industry | Miscellaneous manufacturing industries | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 1994 | 1996 |
| Metric | ODC | AORT |
|---|---|---|
| Price | $76.62 | $23.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.40 |
| AVG Volume (30 Days) | 33.2K | ★ 640.2K |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | 50.45 | ★ 165.62 |
| EPS | ★ 1.69 | 0.03 |
| Revenue | ★ $485,572,000.00 | $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ $46.19 | $765.67 |
| Revenue Growth | 10.97 | ★ 18.01 |
| 52 Week Low | $45.61 | $19.16 |
| 52 Week High | $79.20 | $48.25 |
| Indicator | ODC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 61.30 | 23.06 |
| Support Level | $70.67 | $19.16 |
| Resistance Level | N/A | $38.43 |
| Average True Range (ATR) | 2.02 | 1.97 |
| MACD | 0.06 | -1.40 |
| Stochastic Oscillator | 66.45 | 21.21 |
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.